Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renaud Louis

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Pulmonology|July 28, 2025
Daily digital biomarkers in the follow-up and clustering of patients with asthmaBernardo Sousa-Pinto, Florence Schleich, Gilles Louis, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
The Lancet. Digital Health|March 5, 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data studyBernardo Sousa-Pinto, Cristina Jácome, Ana Margarida Pereira, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
The Lancet. Respiratory Medicine|June 24, 2026
Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma RegistryEvangelia Fouka, Aruna T Bansal, Kjell Erik Julius Håkansson, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
Allergy|April 12, 2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force ReportJean Bousquet, Mohamed H Shamji, Josep M Anto, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Pulmonology|July 28, 2025
Daily digital biomarkers in the follow-up and clustering of patients with asthmaBernardo Sousa-Pinto, Florence Schleich, Gilles Louis, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
The Lancet. Digital Health|March 5, 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data studyBernardo Sousa-Pinto, Cristina Jácome, Ana Margarida Pereira, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
The Lancet. Respiratory Medicine|June 24, 2026
Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma RegistryEvangelia Fouka, Aruna T Bansal, Kjell Erik Julius Håkansson, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
Allergy|April 12, 2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force ReportJean Bousquet, Mohamed H Shamji, Josep M Anto, et al.
Pageof 25